Related Experiment Video
Updated: Jun 27, 2025
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Structural elucidation of the mesothelin-mucin-16/CA125 interaction
Peter B Rupert1, Matthew Buerger1, Della J Friend1
1Division of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Structure (London, England : 1993)
|May 4, 2024
Summary
Mesothelin (MSLN) and Mucin-16/CA125 are cell-surface proteins involved in cancer progression. This study reveals their molecular binding interface, crucial for understanding cancer metastasis and developing therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Mesothelin (MSLN) and Mucin-16/CA125 are cell-surface glycoproteins normally expressed on mesothelium.
- Both MSLN and Mucin-16/CA125 are overexpressed in various cancers and implicated in metastasis.
- The precise biological functions of MSLN and Mucin-16/CA125, including their interaction, remain largely unknown.
Purpose of the Study:
- To elucidate the molecular details governing the recognition of mesothelin by mucin-16/CA125.
- To understand the structural basis of the MSLN-Mucin-16/CA125 interaction.
- To explore the implications of this interaction for cancer biology and therapeutic strategies.
Main Methods:
- Protein engineering and recombinant production of interacting proteins.
- Qualitative and quantitative binding studies.
- Crystal structure determination of the mesothelin-mucin-16/CA125 complex.
Main Results:
- The crystal structure reveals the molecular interface between mesothelin and mucin-16/CA125.
- The binding interface is small, with a micromolar binding constant, and lacks glycan-mediated interactions.
- Multiple mucin-16/CA125 modules can interact with mesothelin, suggesting avidity effects.
Conclusions:
- The study provides a molecular-level understanding of mesothelin-mucin-16/CA125 recognition.
- The findings suggest that avidity, arising from multivalent interactions, may be critical for the functional consequences of MSLN-Mucin-16/CA125 binding.
- Understanding this interaction has implications for developing targeted cancer therapies.
